Skip to main content

Table 2

From: Plasma levels of soluble urokinase-type plasminogen activator receptor (suPAR) and early mortality risk among patients enrolling for antiretroviral treatment in South Africa

Patient characteristic

Unadjusted association

Adjusted association

 

Mean change log suPAR per unit increase in variable

95% CI

P value

Mean change log suPAR per unit increase in variable

95%CI

P value

Age (years)

-0,0001

-0.0038,

0.0035

0.944

0.0018

-0.0020,

0.0056

0.353

Female

-0.0362

-0.0950,

0.0226

0.227

-0.0615

-0.1228,

-0.0002

0.049

CD4 cell count (cells/μl)

-0.0014

-0.0026,

-0.0005

0.003

-0.0012

-0.0022,

-0.0029

0.011

Log10 viral load (copies/ml)

0.0328

-0.0149,

0.0806

0.177

0.0219

-0.0253,

0.0691

0.361

WHO stage 1,2,3 versus 4

0.0691

0.0140,

0.1243

0.014

0.0566

-0.0003,

0.1136

0.051

Tuberculosis (all cases)

0.0482

-0.0087,

0.1051

0.097

0.0380

-0.0187,

0.0947

0.189

  1. Crude associations between baseline patient characteristics and log10 plasma suPAR concentrations (ng/ml) measured at baseline.